Both generic and brand-name drugmakers are involved with the initiative, including Pfizer, Merck, Novartis, GlaxoSmithKline, Johnson & Johnson, Sanofi and AstraZeneca.
In the statement, the drugmakers highlight key actions they will take to reduce the threat of AMR. The group promises to set new factory standards and review supply chain practices to make sure antibiotic waste does not reach waterways, as well as help ensure antibiotics are used only for patients who need them, among other initiatives.
The announcement comes just one day before the U.N. General Assembly’s high-level meeting on antimicrobial resistance will be held in New York.
More articles on supply chain:
4 things to know about generic price spikes
J&J to acquire Abbott’s eye surgery unit: 5 things to know
Valeant defends drug discount program for two heart drugs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
